Lupus & Connective Tissue Diseases
From the Journals
Intermediate nature of ‘incomplete’ lupus shown in large study
People with incomplete lupus erythematosus exhibit nearly as many disease-related symptoms as do those with systemic lupus erythematosus and often...
From the Journals
Abatacept efficacy differs in trials of giant cell and Takayasu’s arteritis
A pair of new studies offer mixed results regarding the use of the rheumatoid arthritis drug abatacept to treat two forms of large-vessel...
From the Journals
New histopathologic marker may aid dermatomyositis diagnosis
The detection of sarcoplasmic myxovirus resistance A expression in immunohistochemical analysis of muscle biopsy in patients suspected of having...
From the Journals
Macitentan boosts quality of life in PAH patients
Macitentan, a recent addition to the drugs that treat pulmonary arterial hypertension (PAH), improves and stabilizes quality of life for patients...
From the Journals
Nailfold analysis can predict cardiopulmonary complications in systemic sclerosis
Nailfold videocapillaroscopy can help to predict which patients with systemic sclerosis may develop serious cardiopulmonary complications,...
From the Journals
Giant cell arteritis independently raises risk for venous thromboembolism
The risk of venous thromboembolism increases markedly shortly before the diagnosis of giant cell arteritis regardless of glucocorticoid exposure,...
Conference Coverage
MRI useful to distinguish between PACNS and neurosarcoidosis
WASHINGTON - MRI can help to differentiate between neurosarcoidosis and primary angiitis of the central nervous system, according to a single-...
Conference Coverage
Lupus patients may be shortchanged on lipid management
WASHINGTON
Conference Coverage
Prenatal exposure to hydroxychloroquine cuts risk of neonatal cutaneous lupus
WASHINGTON - Prenatal hydroxychloroquine reduces the risk of cutaneous neonatal lupus by 60% among the infants of women with a systemic autoimmune...
Conference Coverage
Low-dose cyclophosphamide unlikely to impair fertility in lupus patients
WASHINGTON - Low-dose pulsed cyclophosphamide doesn't appear to affect ovarian reserve when used to treat women with systemic lupus erythematosus...
Conference Coverage
Mycophenolate puts lupus patients in remission faster than azathioprine
WASHINGTON